Çaku, Artuela

Effect of lovastatin on behavior in children and adults with fragile X syndrome: An open‐label study

Çaku, A., Pellerin, D., Bouvier, P., Riou, E., & Corbin, F. (2014) · American Journal of Medical Genetics Part A

Genetics and Neurodevelopmental DisordersDown syndrome and intellectual disability research

Cited by 77

New insights of altered lipid profile in Fragile X Syndrome

Çaku, A., Seidah, N. G., Lortie, A., Gagné, N., Perron, P., Dubé, J., & Corbin, F. (2017) · PLOS ONE

Genetics and Neurodevelopmental DisordersLipoproteins and Cardiovascular Health

Cited by 36

Implication of hypocholesterolemia in autism spectrum disorder and its associated comorbidities: A retrospective case–control study

Benachenhou, S., Etcheverry, A., Galarneau, L., Dubé, J., & Çaku, A. (2019) · Autism Research

Autism Spectrum Disorder ResearchChild Nutrition and Feeding Issues

Cited by 33

Combining Lovastatin and Minocycline for the Treatment of Fragile X Syndrome: Results From the LovaMiX Clinical Trial

Champigny, C., Morin-Parent, F., Bellehumeur-Lefebvre, L., Çaku, A., Lepage, J.-F., & Corbin, F. (2022) · Frontiers in Psychiatry

Genetics and Neurodevelopmental DisordersAutism Spectrum Disorder Research

Cited by 16

Alteration of Fatty Acid Profile in Fragile X Syndrome

Abolghasemi, A., Carullo, M. P., Aguilera, E. C., Laroui, A., Plantefeve, R., Rojas, D., Benachenhou, S., Ramírez, M. V., Proteau-Lemieux, M., Lepage, J.-F., et al. (2022) · International Journal of Molecular Sciences

Fatty Acid Research and HealthGenetics and Neurodevelopmental Disorders

Cited by 6